RENOVARO INC. - COMMON STOCK
0.5321
31-October-24 15:59:59
15 minutes delayed
Stocks
-0.0079
-1.46%
Today's range
0.5321 - 0.5998
ISIN
N/A
Source
NASDAQ
-
17 Oct 2024 09:15:17 By Nasdaq GlobeNewswire
-
Renovaro Announces Strategic Restructuring and Leadership Transition
16 Oct 2024 09:28:06 By Nasdaq GlobeNewswire
-
19 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
17 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
13 Sep 2024 09:00:00 By Nasdaq GlobeNewswire
-
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
11 Sep 2024 09:15:00 By Nasdaq GlobeNewswire
-
Renovaro, Inc. Announces $10 million in Equity Committed
14 Jun 2024 09:06:00 By Nasdaq GlobeNewswire
-
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
24 May 2024 09:20:00 By Nasdaq GlobeNewswire
-
30 Apr 2024 11:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
18 Apr 2024 08:45:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 09:25:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 10:01:30 By Nasdaq GlobeNewswire
-
13 Feb 2024 09:46:07 By Nasdaq GlobeNewswire
-
13 Feb 2024 09:31:09 By Nasdaq GlobeNewswire
-
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
25 Jan 2024 12:45:00 By Nasdaq GlobeNewswire
-
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
16 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
11 Oct 2023 09:25:00 By Nasdaq GlobeNewswire
-
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
10 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
02 Oct 2023 12:05:40 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >